Riluzole elevates GLT-1 activity and levels in striatal astrocytes
about
Astrocytes in Oligodendrocyte Lineage Development and White Matter PathologyInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryCurrent approaches to enhance glutamate transporter function and expressionSLC transporters as therapeutic targets: emerging opportunitiesHigh-affinity glutamate transporters in chronic pain: an emerging therapeutic targetExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsSmall-molecule activator of glutamate transporter EAAT2 translation provides neuroprotectionPathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulationRiluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii.Riluzole-triggered GSH synthesis via activation of glutamate transporters to antagonize methylmercury-induced oxidative stress in rat cerebral cortex.Riluzole: what it does to spinal and brainstem neurons and how it does it.Glutamate-based anxiolytic ligands in clinical trials.Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicityNew advances on glial activation in health and disease.Targeting astrocytes in major depression.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseTranscriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology.Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress.ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain.Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways.Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression.Targeting astrocytes in bipolar disorder.The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.
P2860
Q26744749-90B3F154-54CB-435F-9A3E-1DEB4A945FA0Q26749497-710747B6-CD89-43E7-A05F-BCD2676235F2Q26996723-F1CB3160-173F-4896-A908-E0F5D1650D40Q27014726-0E6BF439-4710-4372-B2BD-655DF121D593Q27020953-25B32353-57E1-456E-87D1-ABDED4C145E8Q28075692-84D08B7B-D4F9-48EF-BB40-5810E49D338DQ30573062-BFD97E47-23DF-4504-B2B1-82612B2EE15DQ33891870-B467C38B-956F-4AEC-9739-C89ECA58E7AAQ34223052-7CC88E47-EFC6-4169-BFD7-EF3DF90A934EQ35509970-777F5F78-EF50-4610-A5EA-7C88646624F6Q36029739-6A84585E-27C6-4E36-B3B6-E407D9C0457AQ36047101-4BF38FF6-17DA-434E-8C7C-473B25A5779DQ36204023-3D45B42E-2B5C-4653-A8A4-E0A5778B6125Q38011003-66DCF345-82C1-4DC0-A59F-FF0D891494B0Q38110306-D0726D7A-1739-4058-AA30-3A5F884C0EB4Q38234167-893426E5-D83D-4565-A8DD-EC5FF601B992Q38474693-8FDBF74D-E770-4053-92A6-6FCD9B051E45Q38608401-BA2634DF-EF2D-42EF-B01C-6BAA7B78C144Q38729846-658842E9-FD84-4AD0-BBD3-0E56EE7EAD34Q38861849-7DA88380-C598-421C-9C03-6730565EB53CQ40075691-DB412037-6FD0-405B-A81C-D9284834989FQ41722126-4A9B11B0-BA9E-404D-BD80-4FAB8211DBA0Q42289968-B4829A67-F824-4E7E-AC5C-4BFB33F6379DQ47211013-F7BB7F87-81E5-449A-AB54-FF6F90B2D165Q47687949-6B152FD7-F330-400D-9DC6-427BC0FAEB58Q47947143-3208B284-E4B7-456D-8AE3-2BDB67F0988DQ48027976-7572B0FE-063C-491B-9F75-16F5B0A2469CQ52143963-DE402D2B-BD0B-4D2B-87B1-1CA2E6F25C72Q55020340-88703523-5628-4E09-A110-A1D63237862E
P2860
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@ast
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@en
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@nl
type
label
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@ast
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@en
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@nl
prefLabel
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@ast
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@en
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@nl
P2860
P921
P3181
P1476
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
@en
P2093
Marica Carbone
P2860
P3181
P356
10.1016/J.NEUINT.2011.10.017
P407
P577
2011-11-06T00:00:00Z